As GLP-1 medications continue to expand across the U.S., millions of consumers are changing behavior in real timeprioritizing protein, ordering differently, and navigating menus with new intent
These drugs are essential to prevention of rejection but come at a metabolic cost, disrupting glucose metabolism through several mechanisms, including downregulation of transcription of the adiponectin gene which can lead to greater risk for glucose intolerance
Medical aestheticians offering injectable peptides should be well-trained and may consider advanced medical aesthetics courses to ensure they administer these treatments safely and within regulatory guidelines
93% reduction in shedding in clinical trial
Immune System Boost Supports healthy immune system function and cellular protection
MeAgain is the GLP-1-specific food, symptom, medication, and progress tracker